Middle East & Africa Bioprocess Technology Market Forecast to 2028

Middle East & Africa Bioprocess Technology Market Forecast to 2028

Middle East & Africa Bioprocess Technology Market Forecast to 2028 – Regional Analysis By Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, and Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)

Send Enquiry
Item ID: BMIRE00028881 Category: Tag:

$2,100 – $3,500

Description

The Middle East & Africa bioprocess technology market is expected to grow from US$ 1,233.00 million in 2023 to US$ 2,443.75 million by 2028. It is estimated to grow at a CAGR of 14.7% from 2023 to 2028.
Introducing Advanced Bioprocess Technologies Drives Middle East & Africa Bioprocess Technology Market
Advanced bioprocess technologies bridge R&D with production. Several players are introducing a wide range of new bioprocessing technologies in the market. On December 4, 2020, IDBS (a provider of software informatics solutions for the biotech and pharmaceutical industries) announced the launch of Polar. Polar creates a new product category called BioPharma Lifecycle Management (BPLM) to streamline drug development and production in biopharma research. Polar is designed and deployed to rapidly solve challenges associated with workflow, process quality, collaboration, and data analysis that have plagued the existing software solutions, including laboratory information management system (LIMS) and electronic laboratory notebook (ELN). As a result, there will be less human errors and an improvement in overall accuracy. It will reduce manual data processing and transcription, leading to fewer human errors and enhanced overall accuracy. It also has extensive search features that make it easier for users to locate what they are searching for, preventing the need for pointless duplication of effort. Merck’s new BioContinuum Platform advances biotherapeutic drug manufacturing through improved efficiency, simplified plant operations, and greater quality and consistency. In addition, Merck’s Pellicon Single-Pass Tangential Flow Filtration aid in intensifying operations associated with the purification of therapeutic proteins. Thus, the introduction of various new-age bioprocess technologies is likely to provide lucrative opportunities for the market growth during the forecast period.
Middle East & Africa Bioprocess Technology Market Overview
The Saudi Food and Drug Authority (SFDA) has experienced lucrative opportunities that benefit from the National Institute for Bioprocessing Research and Training (NIBRT) that support local biotechnology companies. SFDA is highly focused on biotechnology owing to its high importance toward food and drug production, dependence on agriculture, and food and pharmaceutical products. NIBRT Research is a global leader in the development of innovative technologies and involved in advancing biopharmaceutical manufacturing across multidisciplinary areas such as analytical science, cell and genetic engineering, and bioprocess engineering. Such discoveries are utilized to advance the state of the art by revolutionizing the manufacturing of recombinant proteins, vaccines and cells, and gene therapies.
Middle East & Africa Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Bioprocess Technology Market Segmentation
The Middle East & Africa bioprocess technology market is segmented into type, modality, end user, and country.
Based on type, the Middle East & Africa bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. In 2023, the consumables & accessories segment registered a largest share in the Middle East & Africa bioprocess technology market.
Based on modality, the Middle East & Africa bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the Middle East & Africa bioprocess technology market.
Based on end user, the Middle East & Africa bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered a largest share in the Middle East & Africa bioprocess technology market.
Based on country, the Middle East & Africa bioprocess technology market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. In 2023, Saudi Arabia segment registered a largest share in the Middle East & Africa bioprocess technology market.
Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; and Thermo Fisher Scientific Inc are the leading companies operating in the Middle East & Africa bioprocess technology market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 14.7% CAGR, the Middle East & Africa Bioprocess Technology Market is speculated to be worth US$ 2,443.75 million by 2028, says the research team
According to the research team’ research, the Middle East & Africa bioprocess technology market was valued at US$ 1,233.00 million in 2023 and is expected to reach US$ 2,443.75 million by 2028, registering a CAGR of 14.7% from 2023 to 2028. Emergence of automated real-time flow cytometry (ART‐FCM) and introducing advanced bioprocess technologies are the critical factors attributed to the Middle East & Africa bioprocess technology market expansion.
Pharmaceutical companies are spending huge sum in R&D to introduce new molecules with Flow cytometry (FCM) and its technological possibilities have greatly advanced in the past decade as an analysis tool for single-cell properties and population distributions of different cell types in bioreactors. Along the way, a few automated real-time flow cytometry (ART‐FCM) solutions were developed for monitoring bioreactor processes without operator interference over extended periods with a variable sampling frequency. ART‐FCM enables long‐term measurements without missing any important events in bioprocesses and uncovers temporal phenomena that are likely unknown and should be investigated in greater detail. Also, more frequent measurements can be performed at a user-defined frequency, independent of the availability of personnel. When compared with methods such as omics that are only partially available on a single-cell level, multi-parameter measurements can be easily established without the extended effort of labor and time via ART-FCM. Compared with conventional FCM studies, microfluidic devices great future potential as ART‐FCM on a chip. In this context, parallelization might become more relevant, as samples from different bioreactors or different locations inside a bioreactor setup could be analyzed simultaneously. Many aspects might also be adapted to other experimental setups where fast and reproducible real-time monitoring of fluorescent process parameters is also of interest. In conclusion, ART‐FCM will most probably advance exponentially in the upcoming years.
On the contrary, stringent regulatory policies hurdles the growth of Middle East & Africa bioprocess technology market.
Based on type, the Middle East & Africa bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, and consumables & accessories, and others. The consumables & accessories segment held 44.8% share of Middle East & Africa bioprocess technology market in 2023, amassing US$ 552.40 million. It is projected to garner US$ 1,088.72 million by 2028 to expand at 14.5% CAGR during 2023-2028.
Based on modality, the Middle East & Africa bioprocess technology market is bifurcated into single use and multiple use. The single use segment held 85.8% share of Middle East & Africa bioprocess technology market in 2023, amassing US$ 1,057.37 million. It is projected to garner US$ 2,078.53 million by 2028 to expand at 14.5% CAGR during 2023-2028.
Based on end-use, the Middle East & Africa bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. The biopharmaceutical companies segment held 61.1% share of Middle East & Africa bioprocess technology market in 2023, amassing US$ 752.95 million. It is projected to garner US$ 1,489.87 million by 2028 to expand at 14.6% CAGR during 2023-2028.
Based on country, the Middle East & Africa bioprocess technology market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 33.9% share of Middle East & Africa bioprocess technology market in 2023. It was assessed at US$ 417.37 million in 2023 and is likely to hit US$ 814.99 million by 2028, exhibiting a CAGR of 14.3% during the forecast period.
Key players profiled in the Middle East & Africa bioprocess technology market report are Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; and Thermo Fisher Scientific Inc, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africabioprocess technology market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africabioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving thebioprocess technology market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Bioprocess Technology Market – by Type
1.3.2 Middle East & Africa Bioprocess Technology Market – by Modality
1.3.3 Middle East & Africa Bioprocess Technology Market – by End User
1.3.4 Middle East & Africa Bioprocess Technology Market – by Country
2. Middle East & Africa Bioprocess Technology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioprocess Technology Market – Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Middle East & Africa Bioprocess Technology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies
5.3 Market Opportunities
5.3.1 Introducing Advanced Bioprocess Technologies
5.4 Future Trends
5.4.1 Emergence of Automated Real-Time Flow Cytometry (ART-FCM)
5.5 Impact Analysis
6. Bioprocess Technology Market – Middle East & Africa Analysis
6.1 Middle East & Africa Bioprocess Technology Market Revenue Forecast and Analysis
7. Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Middle East & Africa Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
7.3 Cell Culture Media Bioprocess
7.3.1 Overview
7.3.2 Cell Culture Media Bioprocess: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Chromatography Bioprocess
7.4.1 Overview
7.4.2 Chromatography Bioprocess: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Consumables & Accessories
7.5.1 Overview
7.5.2 Consumables & Accessories: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Bioprocess Technology Market Analysis and Forecasts to 2028 – by Modality
8.1 Overview
8.2 Middle East & Africa Bioprocess Technology Market, by Modality 2022 & 2028 (%)
8.3 Single Use
8.3.1 Overview
8.3.2 Single Use: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Multiple Use
8.4.1 Overview
8.4.2 Multiple Use: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Middle East & Africa Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
9.3 Academic & Medical Institutions
9.3.1 Overview
9.3.2 Academic & Medical Institutions: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Biopharmaceutical Companies
9.4.1 Overview
9.4.2 Biopharmaceutical Companies: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1 Middle East & Africa: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
10.1.1.1 UAE: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 UAE: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 UAE: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.1.4 UAE: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.1.5 UAE Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.1.2 Saudi Arabia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Saudi Arabia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.2.4 Saudi Arabia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.2.5 Saudi Arabia Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.1.3 South Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 South Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.3.4 South Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.3.5 South Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
11. Middle East & Africa Bioprocess Technology Market – Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Merck KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sartorius AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Lonza Group AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eppendorf SE
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Repligen Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Danaher Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Research Team
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Middle East & Africa Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
Table 2. UAE Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. UAE Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Saudi Arabia Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 7. Saudi Arabia Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. South Africa Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. South Africa Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of Middle East & Africa Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of Middle East & Africa Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of Middle East & Africa Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. Recent Organic Growth Strategies in Bioprocess Technology Market
Table 15. Recent Inorganic Growth Strategies in the Middle East & Africa bioprocess technology market
Table 16. Glossary of Terms

LIST OF FIGURES

Figure 1. Middle East & Africa Bioprocess Technology Market Segmentation
Figure 2. Middle East & Africa Bioprocess Technology Market, by Country
Figure 3. Middle East & Africa Bioprocess Technology Market Overview
Figure 4. Others Segment Held Largest Share of Type Segment in Middle East & Africa Bioprocess Technology Market
Figure 5. UAE Expected to Show Remarkable Growth During Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Middle East & Africa Bioprocess Technology Market Impact and Analysis
Figure 9. Middle East & Africa Bioprocess Technology Market – Revenue Forecast and Analysis – 2020-2028
Figure 10. Middle East & Africa Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
Figure 11. Cell Culture Media Bioprocess: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Chromatographic Bioprocess: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Consumables & Accessories: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Middle East & Africa Bioprocess Technology Market, by Modality 2022 & 2028 (%)
Figure 16. Single Use: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Use: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Middle East & Africa Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
Figure 19. Academic & Medical Institutions: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Biopharmaceutical Companies: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Research Laboratories: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East & Africa: Bioprocess Technology Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. UAE: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Saudi Arabia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. South Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of Middle East & Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies – Middle East & Africa Bioprocess Technology Market

o Danaher Corp
o Eppendorf SE
o Lonza Group AG
o Merck KGaA
o Repligen Corp
o Sartorius AG
o Thermo Fisher Scientific Inc

Reviews

There are no reviews yet.

Be the first to review “Middle East & Africa Bioprocess Technology Market Forecast to 2028”